Evidence map›Paper›PMID 25988811›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2015

Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

J Zuber, S Rosen, B Shonts, B Sprangers, T M Savage, S Richman, S Yang, S P Lau, S DeWolf, D Farber and 8 more

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Tolerance Induction Strategies in Organ Transplantation: Current Status and Future Perspectives.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  9. Article
  10. Chimerism-Mediated Tolerance in Intestinal Transplantation.Gastroenterology clinics of North America · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

J ZuberColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
S RosenColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
B ShontsColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
B SprangersColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
T M SavageColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
S RichmanColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
S YangColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
S P LauColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
S DeWolfColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
D FarberColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
G VladDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
E ZornColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
W WongColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
J EmondDepartment of Surgery, Columbia University Medical Center, New York, NY.
B LevinDepartment of Biostatistics, Columbia University Medical Center, New York, NY.
M MartinezDepartments of Pediatrics, Columbia University Medical Center, New York, NY.
T KatoDepartment of Surgery, Columbia University Medical Center, New York, NY.
M SykesColumbia Center for Translational Immunology, Columbia University Medical Center, New York, NY.
Columbia University Irving Medical Center · US

Funding

Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS 1S10RR027050-01A1NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI106697
6 · The paper itself

Abstract

Blood chimerism has been reported sporadically among visceral transplant recipients, mostly in association with graft-vs-host disease (GVHD). We hypothesized that a higher degree of mixed chimerism would be observed in multivisceral (MVTx) than in isolated intestinal (iITx) and isolated liver transplant (iLTx) recipients, regardless of GVHD. We performed a longitudinal prospective study investigating multilineage blood chimerism with flow cytometry in 5 iITx and 4 MVTx recipients up to one year posttransplant. Although only one iITx patient experienced GVHD, T cell mixed chimerism was detected in 8 out of 9 iITx/MVTx recipients. Chimerism was significantly lower in the four subjects who displayed early moderate to severe rejection. Pre-formed high-titer donor-specific antibodies, bound in vivo to the circulating donor cells, were associated with an accelerated decline in chimerism. Blood chimerism was also studied in 10 iLTx controls. Among nonsensitized patients, MVTx recipients exhibited greater T and B cell chimerism than either iITx or iLTx recipients. Myeloid lineage chimerism was present exclusively among iLTx and MVTx (6/13) recipients, suggesting that its presence required the hepatic allograft. Our study demonstrates, for the first time, frequent T cell chimerism without GVHD following visceral transplantation and a possible relationship with reduced rejection rate in MVTx recipients.

Indexed as

Liver TransplantationAdolescentAdultChildChild, PreschoolFemaleFlow CytometryFollow-Up StudiesGraft RejectionGraft vs Host DiseaseHumansInfantIntestinesMaleMiddle AgedProspective Studiesflow cytometrylymphocyte biologymonitoring immunetrafficking

Identifiers

PMID25988811
PMCPMC4575629
OpenAlexW1535378176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.